Hemo AI
AI-powered IV Blood Monitoring Medical Device
StartupHemo AI is a Binyamina-Giv'at Ada-based startup in the Health Tech & Life Sciences sector, established in 2023. AI-powered IV Blood Monitoring Medical Device. Hemo AI was founded by Liron Ben-Bashat Bergman, David Salton, Ron Beloosesky, Gilad Cohen. The company has 1-10 employees. Core technologies: Artificial Intelligence, Platforms & Interfaces.
The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.
- StagePre-Funding
- ProductR&D
- ModelB2B
- Employees1-10
- HQBinyamina-Giv'at Ada
- DistrictCenter District
- Last RoundUndisclosed
Liron Ben-Bashat BergmanCo-founder & CEO
David SaltonCo-Founder & CBO
Ron BelooseskyCo-Founder & Clinical Officer
Gilad CohenCo-Founder and CTO
What does Hemo AI do?
Hemo-ai is developing a solution with real-time alerts for bleeding and sepsis, enhancing patient care and revolutionizing traditional monitoring methods. The company's system provides an automated, wearable, IV blood monitoring system that integrates data aggregation and AI analysis, making it ideal for use in hospitals, ICUs, ambulances, and field hospitals.
Who founded Hemo AI?
Hemo AI was founded in 2023 by Liron Ben-Bashat Bergman (Co-founder & CEO), David Salton (Co-Founder & CBO), Ron Beloosesky (Co-Founder & Clinical Officer), Gilad Cohen (Co-Founder and CTO).
What sector is Hemo AI in?
Hemo AI operates in Health Tech & Life Sciences, with core technologies in Artificial Intelligence, Platforms & Interfaces. Target customers: Government & City, Defense, Safety & Security, Safety, Healthcare & Life Sciences.
Where is Hemo AI located?
Hemo AI is based in Ha-Shoshana St 18, Binyamina-Giv'at Ada, Israel, Center District.